News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer

Information on the total number of voting rights and shares

Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation

Nyxoah S.A. (NASDAQ: NYXH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock, up previously from $18.00.

Nyxoah S.A. (NASDAQ: NYXH) had its price target raised by analysts at Stifel Nicolaus from $20.00 to $27.00. They now have a "buy" rating on the stock.

3/5/2024

04:05 pm

nyxh

-8.3%

MISS

11/8/2023

04:05 pm

nyxh

-15.1%

BEAT

8/8/2023

04:05 pm

nyxh

0.1%

BEAT

5/16/2023

04:05 pm

nyxh

-2.9%

MISS

Form 6-K Nyxoah SA For: Apr 15

Form 20-F Nyxoah SA For: Dec 31

Form 6-K Nyxoah SA For: Mar 19

Form 6-K Nyxoah SA For: Mar 05

Form SC 13G/A Nyxoah SA Filed by: TOGETHER PARTNERSHIP

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}